Literature DB >> 9048674

Dipole modeling in epilepsy surgery candidates.

P Boon1, M D'Havé, C Adam, K Vonck, M Baulac, T Vandekerckhove, J De Reuck.   

Abstract

PURPOSE: The validity and clinical significance of dipole modeling in epilepsy surgery candidates is not fully established. PATIENTS AND METHODS: Interictal and ictal dipole modeling was performed in 43 patients with refractory complex partial seizures (CPS) and intracranial structural abnormalities demonstrated with optimum magnetic resonance imaging (MRI: space-occupying, n = 15; atrophic, n = 26; dysplastic, n = 2). Video-EEG monitoring showed CPS in all patients. In 12 patients, additional intracranial EEG monitoring demonstrated hippocampal seizure onset in 11 patients and medial occipital ictal onset in 1.
RESULTS: Spatiotemporal dipole mapping of averaged interictal spikes and epochs of early ictal discharges revealed two distinct dipole patterns. Patients with lesions located in the medial (+/-lateral) temporal lobe (n = 34) and medial occipital lobe (n = 1) uniformly presented a combined interictal dipole that consisted of a radial and a tangential component with a high degree of elevation relative to the axial plane. Eight of 9 patients with extratemporal lesions had a less stable dipole with a predominant radial component. Ictal dipole modeling identified the ictal onset zone correctly as compared with intracranial EEG recordings from bilateral hippocampal depth electrodes. Ictal dipoles showed a striking correspondence with the interictal dipoles in individual patients.
CONCLUSIONS: Interictal and ictal dipole mapping provided additional, reliable, and relevant localizing information in surgical candidates for refractory CPS. Ictal dipole analysis may limit the number of patients who require intracranial electrodes.

Entities:  

Mesh:

Year:  1997        PMID: 9048674     DOI: 10.1111/j.1528-1157.1997.tb01099.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  7 in total

1.  Dipole location errors in electroencephalogram source analysis due to volume conductor model errors.

Authors:  B Vanrumste; G Van Hoey; R Van de Walle; M D'Havé; I Lemahieu; P Boon
Journal:  Med Biol Eng Comput       Date:  2000-09       Impact factor: 2.602

Review 2.  Electroencephalography in epilepsy: look for what could be beyond the visual inspection.

Authors:  Boulenouar Mesraoua; Dirk Deleu; Hassan Al Hail; Gayane Melikyan; Paul Boon; Hiba A Haider; Ali A Asadi-Pooya
Journal:  Neurol Sci       Date:  2019-07-27       Impact factor: 3.307

3.  Seizure localization using EEG analytical signals.

Authors:  Mark H Myers; Akaash Padmanabha; Gavin M Bidelman; James W Wheless
Journal:  Clin Neurophysiol       Date:  2020-06-25       Impact factor: 3.708

4.  Influence of measurement noise and electrode mislocalisation on EEG dipole-source localisation.

Authors:  G Van Hoey; B Vanrumste; M D'Havé; R Van de Walle; I Lemahieu; P Boon
Journal:  Med Biol Eng Comput       Date:  2000-05       Impact factor: 2.602

5.  Effects of head models and dipole source parameters on EEG fields.

Authors:  Li Peng; Mingming Peng; Anhuai Xu
Journal:  Open Biomed Eng J       Date:  2015-02-27

6.  EEG source connectivity to localize the seizure onset zone in patients with drug resistant epilepsy.

Authors:  Willeke Staljanssens; Gregor Strobbe; Roel Van Holen; Vincent Keereman; Stefanie Gadeyne; Evelien Carrette; Alfred Meurs; Francesca Pittau; Shahan Momjian; Margitta Seeck; Paul Boon; Stefaan Vandenberghe; Serge Vulliemoz; Kristl Vonck; Pieter van Mierlo
Journal:  Neuroimage Clin       Date:  2017-09-14       Impact factor: 4.881

7.  Electrical source imaging of interictal spikes using multiple sparse volumetric priors for presurgical epileptogenic focus localization.

Authors:  Gregor Strobbe; Evelien Carrette; José David López; Victoria Montes Restrepo; Dirk Van Roost; Alfred Meurs; Kristl Vonck; Paul Boon; Stefaan Vandenberghe; Pieter van Mierlo
Journal:  Neuroimage Clin       Date:  2016-01-20       Impact factor: 4.881

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.